Talk SCOPE Biotech Forum track
The Small Biotech Sponsor Perspective on AI in Clinical Trials: Separating Real Operational Value from Vendor Hype
Tue, Mar 2, 2027 · 3:30–3:55 PM EST Rosen Shingle Creek
About this session
AI is reshaping clinical research, but adoption without appropriate scrutiny can create as much risk as value. This sponsor-side session separates practical AI applications from vendor hype, exploring where AI can improve trial efficiency, oversight, and decision-making, and where it may introduce operational, quality, privacy, intellectual property, and regulatory risks. Attendees will examine the potential consequences of automation bias, inaccurate outputs, inadequate governance, and diminished human oversight, while gaining a practical framework for evaluating AI solutions based on measurable value, appropriate controls, and potential impact on trial execution.
